33 C
New York
Thursday, June 11, 2026

Tag: LLP

CHAMPION IRON TO HOLD ITS ANNUAL GENERAL MEETING OF SHAREHOLDERS ON AUGUST 27, 2025 (MONTRÉAL) / AUGUST 28, 2025 (SYDNEY)

MONTRÉAL, Aug. 13, 2025 /CNW/ - SYDNEY, August 14, 2025 - Champion Iron Limited (TSX: CIA) (ASX: CIA) (OTCQX: CIAFF) ("Champion" or the "Company") announces...

KARNALYTE RESOURCES INC. ANNOUNCES 2025 SECOND QUARTER RESULTS AND CORPORATE HIGHLIGHTS

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES./ SASKATOON, SK, Aug. 13, 2025 /CNW/ - Karnalyte Resources Inc. ("Karnalyte"...

Shareholders that lost money on Centene Corporation(CNC) should contact Levi & Korsinsky about pending Class Action – CNC

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Centene Corporation ("Centene" or the "Company") (NYSE: CNC) of a class action securities lawsuit.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BellRing Brands, Inc. – BRBR

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of BellRing Brands, Inc. (“BellRing” or the “Company”) (NYSE: BRBR).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.   

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Fiserv, Inc. of Class Action Lawsuit and Upcoming Deadlines – FI

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fiserv, Inc. (“Fiserv” or the “Company”)(NYSE: FI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Apollo Funds to Acquire Kelvion, a Leading Global Provider of Heat Exchange & Cooling Solutions

Triton to retain minority interest in Kelvion
Triton to retain minority interest in Kelvion

Sapiens to be acquired by Advent for $2.5 Billion

Sapiens shareholders to receive $43.50 per share in cash, a 64% premium to Sapiens' undisturbed closing share price of $26.52 on August 8, 2025  KEY...

HEARTWOOD PARTNERS EXITS ITS INVESTMENT IN MICROCARE

NORWALK, Conn., Aug. 13, 2025 /PRNewswire/ -- Heartwood Partners, LLC is pleased to announce that Heartwood Partners III, LP ("Fund III") successfully exited its...

KLC INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against KinderCare Learning Companies, Inc. and Announces Opportunity for Investors with...

SAN DIEGO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers of KinderCare Learning Companies, Inc. (NYSE: KLC) common stock in or traceable to KinderCare’s October 2024 initial public offering (the “IPO”), have until October 14, 2025 to seek appointment as lead plaintiff of the KinderCare class action lawsuit. Captioned Gollapalli v. KinderCare Learning Companies, Inc., No. 25-cv-01424 (D. Or.), the KinderCare class action lawsuit charges KinderCare and certain of KinderCare’s top executives and directors, KinderCare’s controlling shareholder, and the underwriters of the IPO with violations of the Securities Act of 1933.

Global Digital Health Market Poised for Robust Growth at a CAGR of ~18% by 2032 Amid Rising Demand for Remote Care| DelveInsight

The digital health market is experiencing robust growth, driven by increasing adoption of telemedicine, wearable devices, and AI-powered health solutions. Rising healthcare costs and...

Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight

Over the last ten years, cell-based immunotherapy has emerged as a promising approach for treating solid tumors. Several companies, including Iovance Biotherapeutics, Obsidian Therapeutics,...

Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight

Over the last ten years, cell-based immunotherapy has emerged as a promising approach for treating solid tumors. Several companies, including Iovance Biotherapeutics, Obsidian Therapeutics,...

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Novo To Contact Him Directly To Discuss Their Options

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sable Offshore

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Sable Offshore To Contact Him Directly To Discuss Their Options

- A word from our sponsors -

spot_img
HomeTagsLLP